Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease (Q39675706)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 July 2010
edit
Language Label Description Also known as
English
Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease
scientific article published on 21 July 2010

    Statements

    Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease (English)
    Matthew J Walters
    Trageen Baumgart
    Daniel J Dairaghi
    Mark E T Penfold
    Andrew Pennell
    Solomon Ungashe
    J J Kim Wright
    Thomas J Schall

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit